Caprolactam Market Projected to Reach USD 24,113.8 Million by 2034, Growing at a 3.9% CAGR | Future Market Insights, Inc.

Asia-Pacific dominated the market across the world, with the largest consumption from countries, such as China, India and South Korea. Along with textile industry, caprolactam also has significant demand from industrial yarn, and resin and films which are majorly used in the automotive industry.


NEWARK, Del, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The global caprolactam market is on track for significant growth, with estimated sales reaching USD 16,447.9 million in 2024. The market is expected to continue its upward trajectory, achieving a valuation of USD 24,113.8 million by 2034. This growth reflects a steady compound annual growth rate (CAGR) of 3.9% over the forecast period from 2024 to 2034.

Understanding the Caprolactam Market:

The global Caprolactam market, a critical segment within the chemicals industry, plays a pivotal role in the production of nylon-6 fibers and resins. Caprolactam is a key precursor in the manufacturing of nylon-6, a polymer with wide-ranging applications in textiles, automotive, electronics, and industrial sectors. As a result, the demand for Caprolactam is intricately linked to the growth and performance of these industries.

Caprolactam is primarily produced from benzene derivatives through an oxidation process, making it a product heavily dependent on petrochemical supply chains. The polymerization of Caprolactam to form nylon-6 offers properties such as high tensile strength, chemical resistance, and durability, making it ideal for applications that require resilience and longevity.

Caprolactam Market Value by Country:

Country/RegionValue CAGR (2024 to 2034) )
Canada1.8% 
Spain1.9% 
France1.7% 
South Korea2.6% 
China3.3% 
India3.7% 

Advancements in technology are expanding the use of caprolactam in cutting-edge biomedical applications, including controlled drug delivery systems and medical devices. Government initiatives, through supportive policies and incentives, are also fostering its development and integration into pharmaceutical applications. Additionally, the rising utilization of caprolactam in producing surgical tools, implants, and sophisticated medical devices, particularly in China's pharmaceutical sector for manufacturing advanced drug delivery systems like controlled-release capsules, is propelling market growth in the region.

Prominent Drivers of the Caprolactam Market:

  1. Expanding Applications of Nylon-6: The versatility of nylon-6, derived from Caprolactam, is a significant driver of market growth. Nylon-6 is extensively used in the textile industry for producing durable fabrics, in the automotive sector for manufacturing lightweight yet strong components, and in the electronics industry for creating robust and heat-resistant parts. The growing need for high-performance materials in these industries is fueling the demand for Caprolactam.
  2. Technological Advancements in Production: Innovations in Caprolactam production technology, including improved catalyst systems and energy-efficient processes, are enhancing yield and reducing production costs. These advancements are making Caprolactam more accessible and cost-effective, thereby driving its demand across various end-use industries.
  3. Sustainability Initiatives: The global shift towards sustainability and circular economy practices is promoting the use of recyclable materials like nylon-6. Companies are increasingly adopting sustainable practices, including the recycling of nylon products, which involves the depolymerization of nylon-6 back to Caprolactam. This trend is expected to support the market's growth by creating a circular value chain.
  4. Growing Industrialization in Emerging Markets: Rapid industrialization in emerging markets, particularly in Asia-Pacific, is leading to increased demand for Caprolactam. Countries like China and India are witnessing a surge in manufacturing activities, which is driving the need for high-performance materials like nylon-6. As these economies continue to grow, the demand for Caprolactam is expected to follow suit.

Challenges Faced by the Caprolactam Market:

  1. Volatility in Raw Material Prices: Caprolactam production is heavily reliant on benzene, a petrochemical derivative. Fluctuations in crude oil prices directly impact the cost of benzene, leading to volatility in Caprolactam prices. This dependency on petrochemical supply chains poses a significant challenge for manufacturers, as it can affect profitability and pricing strategies.
  2. Environmental Concerns and Regulations: The production of Caprolactam involves chemical processes that can have environmental implications. Stringent environmental regulations aimed at reducing emissions and minimizing the ecological footprint of chemical production are posing challenges for manufacturers. Compliance with these regulations often requires significant investments in cleaner technologies, which can increase production costs.
  3. Competition from Alternative Materials: While nylon-6 offers several advantages, it faces competition from alternative materials like polyester and bio-based polymers. These materials are gaining traction due to their cost-effectiveness and lower environmental impact. The increasing popularity of these alternatives could potentially limit the growth of the Caprolactam market.
  4. Supply Chain Disruptions: The global Caprolactam market is susceptible to supply chain disruptions, particularly in regions that are heavily dependent on imports for raw materials. Geopolitical tensions, trade restrictions, and logistical challenges can impact the steady supply of raw materials, thereby affecting production and market stability.

To Gain More Insights about this Research, Visit!

Competitive Landscape

Leading companies in the caprolactam market are heavily investing in the development of cutting-edge products that offer enhanced reliability and efficiency. Many of these industry players are also focusing on strategic partnerships and acquisitions to expand their global footprint and solidify their market position.

Key Players of the Caprolactam Industry:

  1. Advansix Inc.
  2. Alpek S.A.B. De C.V.
  3. The Aquafil Group
  4. BASF SE
  5. China Petrochemical Development Corporation
  6. DOMO Chemicals
  7. KANTO CHEMICAL CO., INC.
  8. Junsei Chemical Co.,Ltd
  9. Kishida Chemical Co.,Ltd
  10. Merck
  11. UBE Corporation
  12. Otto Chemie Pvt. Ltd

Recent Industry Developments in the Caprolactam Market:

  • In July 2022, Genomatica, in collaboration with Aquafil, successfully completed the first large-scale production run of their plant-based nylon-6. The company is now exploring the application of this material in sectors such as textiles, carpets, and engineering plastics.
  • In March 2022, DOMO Chemicals, a specialist in engineered material solutions, achieved the milestone of delivering 5 million tonnes of caprolactam at its Leuna facility.
  • In February 2021, Lanxess, a German chemical manufacturer and producer of caprolactam, inaugurated a nitrous oxide reduction plant in Belgium, reinforcing their commitment to sustainability.

Key Segments of the Caprolactam Industry:

By Application:

In terms of Application, the industry is divided into nylon 6 fibres (textile filament, industrial filament, carpet filament, and staple filament), nylon 6 engineering plastics (automotive, electrical & electronics, consumer goods, industrial/machinery, wire & cable and others), films (food packaging, pharmaceutical packaging and agricultural packaging) and others.

By Region:

Key countries of North America, Latin America, Europe, East Asia, South Asia, Middle East and Africa (MEA), and Oceania have been covered in the report.

Author by:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Have a Look at the Related Report from the Caprolactam Market:

The global sales of Medical Carts are estimated to be worth USD 1,136.9 million in 2024 and are anticipated to reach a value of USD 2,817.6 million by 2034. Sales are projected to rise at a CAGR of 9.5% over the forecast period between 2024 and 2034.

The global sales of teleradiology market are estimated to be worth USD 8,894.3 million in 2024 and are anticipated to reach a value of USD 47,748.5 million by 2034.

The global sales of suture needles market are estimated to be worth USD 625.0 million in 2024 and anticipated to reach a value of USD 1,008.3 million by 2034.

The global sales of wearable healthcare devices market are estimated to be worth USD 19,163.1 million in 2024 and anticipated to reach a value of USD 43,327.4 million by 2034

The global sales of ultrasound conductivity gels market are estimated to be worth USD 325.9 million in 2024 and are anticipated to reach a value of USD 690.7 million by 2034.

The global sales of contrast media injectors market is estimated to be worth USD 4,949 million in 2024 and anticipated to reach a value of USD 8,832.8 million by 2034.

The global sales of anaesthesia machines market is estimated to be worth USD 11,126.0 million in 2024 and are anticipated to reach a value of USD 17,780.9 million by 2034.

The global sales of dermal fillers market are estimated to be worth USD 6,411.8 million in 2024 and anticipated to reach a value of USD 8,819.6 million by 2034.

The Acetaminophen-Opioid Combination market is estimated to be worth USD 3,144.1 million in 2024 and is projected to reach a value of USD 4,522.6 million by 2034

The cardiac rehabilitation market is estimated to reach USD 2,343.5 million in 2024. Revenue is estimated to increase at a CAGR of 4.6% between 2024 and 2034.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube